IRMD as of Oct 31 · 16:12 ET
IRMDNasdaqSurgical & Medical Instruments & Apparatus

Iradimed Corp · Brief

Next report

101 days

Feb 9 · before openest.Q4 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
4 of 7≥ implied
avg implied
±7.3%
avg realized
±7.4%
Feb 13 '25±6.3%▼−8.39%×1.33
May 5 '25±7.8%▼−2.19%×0.28
Aug 1 '25±7.4%▲+13.42%×1.82
Nov 3 '25±7.7%▲+9.50%×1.23
Feb 10 '26±6.1%▲+9.57%×1.57
Q1 FY26±7.7%▲+4.45%×0.58
Q2 FY26±7.8%▼−4.57%×0.59
Q3 FY26—▼−10.57%—
quarterimplied−15%0+15%realized×
Q3 FY26—▼−10.57%—
Q2 FY26±7.8%▼−4.57%×0.59
Q1 FY26±7.7%▲+4.45%×0.58
Feb '26±6.1%▲+9.57%×1.57
Nov '25±7.7%▲+9.50%×1.23
Aug '25±7.4%▲+13.42%×1.82
2 older reports
May '25±7.8%▼−2.19%×0.28
Feb '25±6.3%▼−8.39%×1.33
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Feb 9 report · est.

—

Linked exposure

IRMD report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±7.1% into Oct 30 earnings (Oct 29 close).Source
Oct 21impliedImplied move: ±7.2% into Nov 2 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.